Point72 Asset Management’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.5M | Buy |
2,143,900
+1,767,238
| +469% | +$40.8M | 0.1% | 229 |
|
|
2025
Q1 | $10.2M | Sell |
376,662
-244,721
| -39% | -$6.61M | 0.02% | 531 |
|
|
2024
Q4 | $33.3M | Buy |
621,383
+225,508
| +57% | +$12.1M | 0.07% | 289 |
|
|
2024
Q3 | $18M | Buy |
395,875
+259,445
| +190% | +$11.8M | 0.05% | 374 |
|
|
2024
Q2 | $5.72M | Buy |
+136,430
| New | +$5.72M | 0.02% | 610 |
|